Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma | MicrobiomeTrials← Back to trialsNCT01961063
Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2015-12-31Est. Completion: 2027-07-06
Enrollment target: 3 participants Locations- City of Hope Medical Center, Duarte, California, United States
Other microbiome trials you might be interested in
HIVKaposi's SarcomaLymphomasMulticentric Castleman's DiseasePrimary Effusion Lymphoma
BACKGROUND:
* A number of important scientific advances can be made through the study of blood, bone marrow, tumor, or …
Bethesda, United States
Primary Effusion LymphomaB-Cell Neoplasm
Background:
Primary effusion lymphoma (PEL) is a rare disease with no standard treatment. Researchers want to see if a …
Bethesda, United StatesEst. completion Oct 1, 2024